A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...
TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA ...
"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...
Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...
In a compelling Genomic Press Interview published in Brain Medicine on September 25, 2024, Professor Hermona Soreq of the ...
Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable ...
Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing ...
Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...
The Brighterside of News on MSN3h
'Origin-of-life' molecule targets and destroys cancer cellsRecent research from the University of Seville indicates that RNA, the molecule that is responsible for the origin of life, ...
Researchers developed a quick and affordable whole-blood assay to detect autoantibodies against type I IFNs, enabling rapid diagnostics for immune disorders. This new method has potential clinical ...
Altamira’s Senior Management will hold an investor call today, Tuesday, September 24, 2024, at 8:30 a.m. EDT its business update and first half 2024 results. Founder, Chairman, and CEO Thomas Meyer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback